Article

Urinary proteome profiling for stratifying patients with familial Parkinson’s disease

2020-08-10

Abstract excerpt

<h4>SUMMARY</h4> The prevalence of Parkinson’s disease (PD) is increasing but the development of novel treatment strategies and therapeutics altering the course of the disease would benefit from specific, sensitive and non-invasive biomarkers to detect PD early. Here, we describe a scalable and sensitive mass spectrometry (MS)-based proteomic workflow for urinary proteome profiling. Our workflow enabled the repro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a66adde4-9788-5d85-9e76-2dd3bf4d1c0a
DOI: 10.1101/2020.08.09.243584

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Urinary proteome profiling for stratifying patients with familial Parkinson’s diseaseDOI 10.1101/2020.08.09.243584Read

Urinary proteome profiling for stratifying patients with familial Parkinson's disease.Semantic proximity Read

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseSemantic proximity Read

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define diagnostic biosignatures for Parkinson’s DiseaseSemantic proximity Read

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s diseaseSemantic proximity Read

Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson’s diseaseSemantic proximity Read

Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson's disease.Semantic proximity Read

Orthogonal validation of PD Biomarkers: Multi-platform proteomics profiling of CSF, Plasma, and Urine confirms DDC as a consistent candidateSemantic proximity Read

Detection of prodromal Parkinson’s disease using a urine proteomics panel and machine learningSemantic proximity Read

Integrated Biofluid Proteomics Identified Dynamic Functional Biomarkers of <i>LRRK2</i> -Linked Parkinson’s Disease ProgressionSemantic proximity Read

Mapping Parkinson’s Disease Progression through Deep Plasma Proteomics and Functional GenomicsSemantic proximity Read

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s diseaseSemantic proximity Read

Discovery and validation of biomarkers for Parkinson’s disease from human cerebrospinal fluid using mass spectrometry-based proteomics analysisSemantic proximity Read